intranasal glutathione in parkinson& 39 Intranasal nanotherapeutics for brain targeting
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease ScienceDirect Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy PMC Unlocking the potential of lipid based nanoparticles for intranasal drug delivery in Parkinson's disease ScienceDirect Revamping Parkinson's disease therapy using PLGA based drug delivery systems npj Parkinson's Disease Ask the MD: Glutathione and Parkinson's Parkinson's Disease
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




